FY
Highly rated in
17
conditions
Highly rated in
17
conditions
Check Dr. Furhan Yunus' experience treating your condition:
About Dr. Furhan Yunus

Furhan Yunus is an Oncologist and a Hematologist Oncology expert in Mobile, Alabama. Yunus has been practicing medicine for over 37 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Lung Cancer, Paget Disease of the Breast, Breast Cancer, Bone Marrow Aspiration, and Bone Marrow Transplant. He is licensed to treat patients in Mississippi, Tennessee, Arkansas, and Louisiana. Yunus is currently accepting new patients.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Furhan Yunus it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Furhan Yunus accepts the following insurance:

  •  Blue Cross Blue Shield
  •  UnitedHealthcare

Call to see if your plan is accepted.
Locations
1700 Spring Hill Ave, Mobile, AL 36604
Background & Education
Graduate Institution
Other, 1985
Specialties
Oncology
Hematology Oncology
Licenses
Internal Medicine in TN
Hospital Affiliations
North Baldwin Infirmary
Thomas Hospital
Mobile Infirmary
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Molecular Analysis for Therapy Choice (MATCH)
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
A Phase I/II Trial of the Combination of Cisplatin, Cetuximab, and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
View 3 Less Clinical Trials -

12 Total Publications

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors